Andrew Meissen is a New York City-based freelance science writer specializing in neuroscience and technology. His work has appeared in publications such as BrainFacts.org, Photonics Focus and Drug Discovery News.
Andrew Meissen
Contributing Writer
Spectrum
From this contributor
Sequencing trick identifies brain cells affected by large autism-linked mutation
The method, called Orgo-Seq, reveals that a deletion of genes on chromosome 16 increases the proportion of immature neurons and neural precursors in brain organoids derived from people with the mutation.
Sequencing trick identifies brain cells affected by large autism-linked mutation
Explore more from The Transmitter
It’s past time to stop using the Reading the Mind in the Eyes Test
The widely used measure of “theory of mind” needs to be re-examined, along with the long-standing claim that autism is linked to a lack of this ability.
It’s past time to stop using the Reading the Mind in the Eyes Test
The widely used measure of “theory of mind” needs to be re-examined, along with the long-standing claim that autism is linked to a lack of this ability.
Robots boost data consistency in rodent studies reliant on mechanical, optogenetic stimulation
Two new devices take experimenter variation out of the equation, the lead investigators say.
Robots boost data consistency in rodent studies reliant on mechanical, optogenetic stimulation
Two new devices take experimenter variation out of the equation, the lead investigators say.
Spina bifida; MDMA effects in a mouse model of autism; maternal autoantibodies
Here is a roundup of autism-related news and research spotted around the web for the week of 13 May.
Spina bifida; MDMA effects in a mouse model of autism; maternal autoantibodies
Here is a roundup of autism-related news and research spotted around the web for the week of 13 May.